Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004. Case and Commentary Nov 2020 Should a Good Risk Manager Worry About Cost and Price Transparency in Health Care? Josh Charles Hyatt, DHSc, MHL, MBE(c) and Stephen L. Newman, MD, MBA Once focused on hospital liability, risk managers now navigate a broader set of enterprise risk management responsibilities. AMA J Ethics. 2020;22(11):E924-932. doi: 10.1001/amajethics.2020.924. Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019;21(2):E138-145. doi: 10.1001/amajethics.2019.138. Case and Commentary Feb 2019 Should Watson Be Consulted for a Second Opinion? David D. Luxton, PhD, MS Guidance for organizations using AI tools to diagnose and to develop treatment recommendations can also help clinicians consider risks and benefits. AMA J Ethics. 2019;21(2):E131-137. doi: 10.1001/amajethics.2019.131. Case and Commentary Mar 2020 How Should Organizations Respond to Repeated Noncompliance by Prominent Researchers? Min-Fu Tsan, MD, PhD and Grace L. Tsan, OD IRBs must report human subject research protocol deviations and university leadership might also need to motivate compliance with federal regulations. AMA J Ethics. 2020;22(3):E201-208. doi: 10.1001/amajethics.2020.201. Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 1 Patrick D. Guinan, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505. Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 2 Malika Haque, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505. Case and Commentary May 2005 Patient Counseling and Matters of Conscience, Commentary 1 Farr Curlin, MD Virtual Mentor. 2005;7(5):352-358. doi: 10.1001/virtualmentor.2005.7.5.ccas3-0505. Case and Commentary May 2005 Patient Counseling and Matters of Conscience, Commentary 2 Rev. Russell Burck, PhD Virtual Mentor. 2005;7(5):352-358. doi: 10.1001/virtualmentor.2005.7.5.ccas3-0505. Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004.
Case and Commentary Nov 2020 Should a Good Risk Manager Worry About Cost and Price Transparency in Health Care? Josh Charles Hyatt, DHSc, MHL, MBE(c) and Stephen L. Newman, MD, MBA Once focused on hospital liability, risk managers now navigate a broader set of enterprise risk management responsibilities. AMA J Ethics. 2020;22(11):E924-932. doi: 10.1001/amajethics.2020.924.
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019;21(2):E138-145. doi: 10.1001/amajethics.2019.138.
Case and Commentary Feb 2019 Should Watson Be Consulted for a Second Opinion? David D. Luxton, PhD, MS Guidance for organizations using AI tools to diagnose and to develop treatment recommendations can also help clinicians consider risks and benefits. AMA J Ethics. 2019;21(2):E131-137. doi: 10.1001/amajethics.2019.131.
Case and Commentary Mar 2020 How Should Organizations Respond to Repeated Noncompliance by Prominent Researchers? Min-Fu Tsan, MD, PhD and Grace L. Tsan, OD IRBs must report human subject research protocol deviations and university leadership might also need to motivate compliance with federal regulations. AMA J Ethics. 2020;22(3):E201-208. doi: 10.1001/amajethics.2020.201.
Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 1 Patrick D. Guinan, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505.
Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 2 Malika Haque, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505.
Case and Commentary May 2005 Patient Counseling and Matters of Conscience, Commentary 1 Farr Curlin, MD Virtual Mentor. 2005;7(5):352-358. doi: 10.1001/virtualmentor.2005.7.5.ccas3-0505.
Case and Commentary May 2005 Patient Counseling and Matters of Conscience, Commentary 2 Rev. Russell Burck, PhD Virtual Mentor. 2005;7(5):352-358. doi: 10.1001/virtualmentor.2005.7.5.ccas3-0505.